Amarex Celebrates 20 Years of Clinical Product Development and Approvals
Germantown, MD, USA (December 31, 2018) – December 30, 2018, Amarex celebrated its twentieth anniversary, commemorating two decades of clinical product development and approvals for our clients. Over the last 20 years, Amarex has grown from a two person company focused on biostatistics and regulatory services to a full service CRO of approximately 100 employees. Among its many achievements, Amarex has been proud to help obtain FDA approval for 20 different products across a wide range of medical conditions.
Leading up to this anniversary, Amarex announced earlier in the year the official opening of an office for its affiliate organization, Amarex Taiwan, which provides direct services to biotech, pharmaceutical and medical device companies across Asia. Amarex also anticipates the official office opening of its European affiliate in 2019, which will further support the existing team in Europe.
Amarex’s continued progress reflects the company’s ongoing commitment to advanced clinical product development. President and CEO, Dr. Kazem Kazempour, who co-founded and has led the company from its start, stated that “Amarex was created to offer improved quality and efficiency of clinical research services. We established processes and procedures to directly impact the time and cost of drug and medical device development, while using a highly consultative approach with our clients. We are grateful for our achievements over the past two decades, having grown from a two person company to the full-service CRO that it is today.”
Amarex kicked-off its anniversary celebration with internal staff, close friends and family at its annual holiday party earlier this month.
Amarex is a global, full service Contract Research Organization (CRO), whose leadership team has significant expertise conducting biomedical research, and whose combined experience includes the design and conduct of several hundred clinical research projects in many therapeutic indications. Amarex provides comprehensive services in Project Management (Phase I-IV, BE/BA, PK/PD), Regulatory Affairs, FDA Applications and Submissions, Applications and Submissions to international Health Authorities, GxP Compliance Audits, Clinical Operations, Adaptive Study Designs, Statistical Analysis, Data Management and General Consulting. Amarex has taken clients’ products through the entire approval process from writing the initial product approval strategy to the marketing approval application with a growing list of approved products. Amarex is committed to cost effective, high quality clinical product development. For more information, visit www.amarexcro.com.
Book a meeting or send us a message to talk to one of our experts.